NCT04932252View on ClinicalTrials.gov

A Study of A4368 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

July 25, 2022

Study Completion Date

July 25, 2022

Conditions
Health Subjects
Interventions
DRUG

A4368 or placebo tablet

orally administered

Trial Locations (1)

Unknown

AutophagySciences, Seoul

All Listed Sponsors
lead

Autophagy Sciences, Inc.

INDUSTRY

NCT04932252 - A Study of A4368 in Healthy Subjects | Biotech Hunter | Biotech Hunter